198 related articles for article (PubMed ID: 37405587)
1. The orchestrating role of deteriorating neurons and TREM-1 in crosstalk with SYK in Alzheimer's disease progression and neuroinflammation.
Anwar MM
Inflammopharmacology; 2023 Oct; 31(5):2303-2310. PubMed ID: 37405587
[TBL] [Abstract][Full Text] [Related]
2. Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke.
Xu P; Zhang X; Liu Q; Xie Y; Shi X; Chen J; Li Y; Guo H; Sun R; Hong Y; Liu X; Xu G
Cell Death Dis; 2019 Jul; 10(8):555. PubMed ID: 31324751
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TREM-1 alleviates neuroinflammation by modulating microglial polarization via SYK/p38MAPK signaling pathway after traumatic brain injury.
Zhao T; Zhou Y; Zhang D; Han D; Ma J; Li S; Li T; Hu S; Li Z
Brain Res; 2024 Jul; 1834():148907. PubMed ID: 38570153
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effect of methylsulfonylmethane against BPA/γ-radiation induced neurodegenerative alterations in rats: Influence of TREM-2/DAP-12/Syk pathway.
Abdel-Rafei MK; Thabet NM
Life Sci; 2020 Nov; 260():118410. PubMed ID: 32926927
[TBL] [Abstract][Full Text] [Related]
5. Neuronal Spleen tyrosine kinase (SYK) mediates cytokine release in Transgenic Tau P301S mice organotypic brain slice cultures.
Schweig JE; Yao H; Jin C; Crawford F; Mullan M; Paris D
Neurosci Lett; 2020 Jun; 729():134992. PubMed ID: 32334108
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic acid modulates microglial TREM-2 gene in Phytohaemagglutinin-Induced in vitro model of Alzheimer's disease like pathology.
Amir A; Shahid M; Farooq Khan S; Nisar U; Faizi S; Usman Simjee S
Brain Res; 2024 Feb; 1824():148686. PubMed ID: 38008243
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Inhibition of Spleen Tyrosine Kinase Suppressed Neuroinflammation and Cognitive Dysfunction in LPS-Induced Neurodegeneration Model.
Kim MW; Choe K; Park JS; Lee HJ; Kang MH; Ahmad R; Kim MO
Cells; 2022 May; 11(11):. PubMed ID: 35681471
[TBL] [Abstract][Full Text] [Related]
9. Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation
Schweig JE; Yao H; Coppola K; Jin C; Crawford F; Mullan M; Paris D
J Biol Chem; 2019 Sep; 294(36):13378-13395. PubMed ID: 31324720
[TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
[TBL] [Abstract][Full Text] [Related]
11. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice.
Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z
MAbs; 2022; 14(1):2107971. PubMed ID: 35921534
[TBL] [Abstract][Full Text] [Related]
12. Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease.
Ghosh S; Geahlen RL
EBioMedicine; 2015 Nov; 2(11):1785-98. PubMed ID: 26870803
[TBL] [Abstract][Full Text] [Related]
13. Tryptophanyl-tRNA Synthetase 1 Signals Activate TREM-1 via TLR2 and TLR4.
Nguyen TTT; Yoon HK; Kim YT; Choi YH; Lee WK; Jin M
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32899943
[TBL] [Abstract][Full Text] [Related]
14. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.
Köhler C; Fuhr V; Dinekov M
Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467
[TBL] [Abstract][Full Text] [Related]
15. TREM (Triggering Receptor Expressed on Myeloid Cells)-1 Inhibition Attenuates Neuroinflammation via PKC (Protein Kinase C) δ/CARD9 (Caspase Recruitment Domain Family Member 9) Signaling Pathway After Intracerebral Hemorrhage in Mice.
Lu Q; Liu R; Sherchan P; Ren R; He W; Fang Y; Huang Y; Shi H; Tang L; Yang S; Zhang JH; Tang J
Stroke; 2021 Jun; 52(6):2162-2173. PubMed ID: 33947214
[TBL] [Abstract][Full Text] [Related]
16. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ; Roberts AM; Delgado DD; Nichols RA
J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
[TBL] [Abstract][Full Text] [Related]
17. TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer.
Yao Y; Li H; Chen J; Xu W; Yang G; Bao Z; Xia D; Lu G; Hu S; Zhou J
Oncotarget; 2016 May; 7(20):29620-34. PubMed ID: 27102437
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer's disease.
Ruganzu JB; Peng X; He Y; Wu X; Zheng Q; Ding B; Lin C; Guo H; Yang Z; Zhang X; Yang W
Mol Immunol; 2022 Feb; 142():22-36. PubMed ID: 34959070
[TBL] [Abstract][Full Text] [Related]
19. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets.
Cai Y; Liu J; Wang B; Sun M; Yang H
Front Immunol; 2022; 13():856376. PubMed ID: 35558075
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.
Wang M; Tang G; Zhou C; Guo H; Hu Z; Hu Q; Li G
Chem Biol Interact; 2023 Apr; 375():110387. PubMed ID: 36758888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
